BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6797298)

  • 1. Nocturnal gastric acid secretion in duodenal ulcer: inhibition by cimetidine.
    Broor SL; Shrestha GP; Mehta SK; Sharma BK
    Am J Med Sci; 1981; 282(3):120-4. PubMed ID: 6797298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of transdermal scopolamine, alone or in combination with cimetidine, on total 24 hour gastric acid secretion in patients with duodenal ulcer.
    Richardson CT; Feldman M
    Gut; 1986 Dec; 27(12):1493-7. PubMed ID: 3804025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tiotidine, a new H2-receptor antagonist, is a potent inhibitor of nocturnal acid secretion in duodenal ulcer patients.
    Valenzuela JE; Strecker RB; Douglas AP
    Dig Dis Sci; 1981 May; 26(5):433-7. PubMed ID: 6113920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cimetidine or vagotomy? Comparison of the effects of proximal gastric vagotomy, cimetidine and placebo on nocturnal intragastric acidity and acid secretion in patients with cimetidine resistant duodenal ulcer.
    Gledhill T; Buck M; Paul A; Hunt RH
    Br J Surg; 1983 Dec; 70(12):704-6. PubMed ID: 6640248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of treatment with cimetidine for one year on gastrin cell and parietal cell function and sensitivity to cimetidine in patients with duodenal or gastric ulcers.
    Festen HP; Lamers CB; Tangerman A; van Tongeren JH
    Postgrad Med J; 1980 Oct; 56(660):698-701. PubMed ID: 7220403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parietal and chief cell sensitivity to pentagastrin stimulation before and after cimetidine treatment for duodenal ulcer.
    Aadland E; Berstad A
    Scand J Gastroenterol; 1979; 14(1):111-14. PubMed ID: 370968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Twenty-four-hour intragastric acidity and nocturnal gastric secretion in gastric ulcer patients--the effects of cimetidine.
    Derodra JK; Howden CW; Burget DW; Hunt RH
    Aliment Pharmacol Ther; 1990 Jun; 4(3):275-81. PubMed ID: 2104090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of nocturnal acid secretion in duodenal ulcer patients by an H-2 histamine antagonist-cimetidine. A controlled double-blind investigation.
    Hollander D; Hossain Z; Sufi AM
    Am J Dig Dis; 1976 May; 21(6):361-5. PubMed ID: 7135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cimetidine on gastric secretion and duodenogastric reflux.
    Melville RJ; Suleiman SI; Whitfield PF; Parkin JV; Nwabunike TO; Hobsley M
    Gut; 1985 Aug; 26(8):766-9. PubMed ID: 4018640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single nocturnal dose of an H2 receptor antagonist for the treatment of duodenal ulcer.
    Gledhill T; Howard OM; Buck M; Paul A; Hunt RH
    Gut; 1983 Oct; 24(10):904-8. PubMed ID: 6311692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total 24-hour gastric acid secretion in patients with duodenal ulcer. Comparison with normal subjects and effects of cimetidine and parietal cell vagotomy.
    Feldman M; Richardson CT
    Gastroenterology; 1986 Mar; 90(3):540-4. PubMed ID: 3943686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment failure of cimetidine in duodenal ulcer (author's transl)].
    Gugler R; Rohner HG; Somogyi AA
    Dtsch Med Wochenschr; 1982 Jul; 107(27):1054-7. PubMed ID: 7084071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of ranitidine, cimetidine and placebo on the 24 hour intragastric acidity and nocturnal acid secretion in patients with duodenal ulcer.
    Walt RP; Male PJ; Rawlings J; Hunt RH; Milton-Thompson GJ; Misiewicz JJ
    Gut; 1981 Jan; 22(1):49-54. PubMed ID: 6109686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omeprazole inhibition of nocturnal gastric secretion in patients with duodenal ulcer.
    Hetzel DJ; Shearman DJ
    Br J Clin Pharmacol; 1984 Oct; 18(4):587-90. PubMed ID: 6487498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Does the degree of reduction of gastric acid secretion change during cimetidine therapy of duodenal ulcer?].
    Stimpel HR; Lawaetz O; Dragsted J; Linde J
    Ugeskr Laeger; 1983 Mar; 145(12):897-9. PubMed ID: 6857789
    [No Abstract]   [Full Text] [Related]  

  • 16. Double blind comparison between cimetidine and gefarnate in cases of duodenal ulcer.
    Cambielli M; Evangelista A; Guslandi M; Bierti L; Benvenuti C; Tittobello A
    Acta Hepatogastroenterol (Stuttg); 1979 Aug; 26(4):326-30. PubMed ID: 386698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and pharmacological effectiveness of cimetidine in duodenal ulcer patients.
    Ruen SJ; Hesselfeldt P; Larsen NE
    Scand J Gastroenterol; 1979; 14(4):489-92. PubMed ID: 482861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interrelationship between gastric acidity and gastrin concentration in patients with duodenal or gastric ulcer and in healthy subjects.
    Mahachai V; Walker K; Pinchbeck B; Thomson AB
    Clin Ther; 1985; 7(4):424-41. PubMed ID: 4016826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Has cimetidine revolutionised the medical treatment of peptic ulceration?
    Pounder RE
    J Hum Nutr; 1979 Oct; 33(5):367-70. PubMed ID: 501076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of one-month treatment with cimetidine on gastric secretion and serum gastrin and pepsinogen levels.
    Sewing KF; Hagie L; Ippoliti AF; Isenberg JI; Samloff IM; Sturdevant RA
    Gastroenterology; 1978 Feb; 74(2 Pt 2):276-9. PubMed ID: 620908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.